These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 2137748)

  • 21. QT dispersion and autonomic nervous system function in patients with type 1 diabetes.
    Aytemir K; Aksöyek S; Ozer N; Gürlek A; Oto A
    Int J Cardiol; 1998 Jun; 65(1):45-50. PubMed ID: 9699930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased QT dispersion in patients with insulin-dependent diabetes mellitus.
    Arildsen H; May O; Christiansen EH; Damsgaard EM
    Int J Cardiol; 1999 Dec; 71(3):235-42. PubMed ID: 10636529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation of altered Q-T interval and sympathetic nervous system dysfunction in diabetic autonomic neuropathy.
    Oka H; Mochio S; Sato K; Isogai Y
    Eur Neurol; 1994; 34(1):23-9. PubMed ID: 8137835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. QT interval, cardiovascular risk factors and risk of death in diabetes.
    Veglio M; Chinaglia A; Cavallo-Perin P
    J Endocrinol Invest; 2004 Feb; 27(2):175-81. PubMed ID: 15129815
    [TBL] [Abstract][Full Text] [Related]  

  • 25. QT interval prolongation in type 2 (non-insulin-dependent) diabetic patients with cardiac autonomic neuropathy.
    Jermendy G; Koltai MZ; Pogátsa G
    Acta Diabetol Lat; 1990; 27(4):295-301. PubMed ID: 2087930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Corrected QT interval in relation to the severity of diabetic autonomic neuropathy.
    Tentolouris N; Katsilambros N; Papazachos G; Papadogiannis D; Linos A; Stamboulis E; Papageorgiou K
    Eur J Clin Invest; 1997 Dec; 27(12):1049-54. PubMed ID: 9466135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can abnormalities of ventricular repolarisation identify insulin dependent diabetic patients at risk of sudden cardiac death?
    Weston PJ; Glancy JM; McNally PG; Thurston H; de Bono DP
    Heart; 1997 Jul; 78(1):56-60. PubMed ID: 9290403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between QT dispersion and autonomic dysfunction in patients with diabetes mellitus.
    Wei K; Dorian P; Newman D; Langer A
    J Am Coll Cardiol; 1995 Oct; 26(4):859-63. PubMed ID: 7560609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autonomic neuropathy and QT interval in hemodialysed patients.
    Maule S; Veglio M; Mecca F; Calvo C; Martina G; Marangella M; Quadri R; Cavallo Perin P
    Clin Auton Res; 2004 Aug; 14(4):233-9. PubMed ID: 15316840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Importance of cardiovascular autonomic dysfunction in IDDM subjects with diabetic nephropathy.
    Zander E; Schulz B; Heinke P; Grimmberger E; Zander G; Gottschling HD
    Diabetes Care; 1989 Apr; 12(4):259-64. PubMed ID: 2707113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Standing to lying heart rate variation. A new simple test in the diagnosis of diabetic autonomic neuropathy.
    Bellavere F; Cardone C; Ferri M; Guarini L; Piccoli A; Fedele D
    Diabet Med; 1987; 4(1):41-3. PubMed ID: 2951218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced gastric emptying and mesenteric blood flow in IDDM with cardiac autonomic neuropathy.
    Weck M; Ott P; Matthies K
    Acta Med Austriaca; 1997; 24(5):180-4. PubMed ID: 9428944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heart-rate variability and cardiac autonomic function in diabetes.
    Malpas SC; Maling TJ
    Diabetes; 1990 Oct; 39(10):1177-81. PubMed ID: 2210071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. QT interval prolongation and mortality in type 1 diabetic patients: a 5-year cohort prospective study. Neuropathy Study Group of the Italian Society of the Study of Diabetes, Piemonte Affiliate.
    Veglio M; Sivieri R; Chinaglia A; Scaglione L; Cavallo-Perin P
    Diabetes Care; 2000 Sep; 23(9):1381-3. PubMed ID: 10977037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. QT interval length and diabetic autonomic neuropathy.
    Ewing DJ; Neilson JM
    Diabet Med; 1990 Jan; 7(1):23-6. PubMed ID: 2137059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. QT interval variability in type 2 diabetic patients with cardiac sympathetic dysinnervation assessed by 123I-metaiodobenzylguanidine scintigraphy.
    Sacre JW; Franjic B; Coombes JS; Marwick TH; Baumert M
    J Cardiovasc Electrophysiol; 2013 Mar; 24(3):305-13. PubMed ID: 23210722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolonged QTc interval predicts mortality in patients with Type 1 diabetes mellitus.
    Rossing P; Breum L; Major-Pedersen A; Sato A; Winding H; Pietersen A; Kastrup J; Parving HH
    Diabet Med; 2001 Mar; 18(3):199-205. PubMed ID: 11318840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac autonomic neuropathy (CAN) in type-1 diabetes mellitus patients and its association with the duration of disease and glycemic control.
    Khoharo HK; Ansari S; Ali Shaikh I; Qureshi F
    J Coll Physicians Surg Pak; 2009 Apr; 19(4):232-5. PubMed ID: 19356338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autonomic neuropathy and prolongation of QT interval in human immunodeficiency virus infection.
    Villa A; Foresti V; Confalonieri F
    Clin Auton Res; 1995 Feb; 5(1):48-52. PubMed ID: 7780290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. QT dispersion and autonomic function in diabetic and non-diabetic patients with renal failure.
    Kirvelä M; Yli-Hankala A; Lindgren L
    Br J Anaesth; 1994 Dec; 73(6):801-4. PubMed ID: 7880670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.